1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, June 2016 (p8)

Biological Therapy Analysis & Statistics, June 2016 (p8)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

211-240 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology, Biological Therapy
  • Countries : United States
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, ...

  • Industries : Biological Therapy, Therapy, Biopharmaceutical, Biotechnology, Cancer, Pathology
  • Countries : United States, World
HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016’, provides in depth analysis on HIV-1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biopharmaceutical, Cancer, Pathology, Biotechnology
  • Countries : United States
Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucin 1 (MUC-1 or Breast Carcinoma-Associated ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Biotechnology, Pharmaceutical
  • Countries : World, United States
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Pancreatic Cancer - Pipeline Review, H1 2016

Pancreatic Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Global and Chinese Cell Culture Dashboard Industry, 2016 Market Research Report

Global and Chinese Cell Culture Dashboard Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • June 2016
  • by Prof Research

The 'Global and Chinese Cell Culture Dashboard Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Cell Culture Dashboard industry with a ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2016 Market Research Report

Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • June 2016
  • by Prof Research

The 'Global and Chinese Embryonic Stem Cell (hESC) Products Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Embryonic Stem Cell (hESC) ...

  • Industries : Biological Therapy
  • Countries : World
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : United States
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Biotechnology, Pathology, Cancer, Pharmaceutical
  • Countries : United States
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme ...

  • Industries : Cancer, Pathology
  • Countries : United States
Acute Lung Injury - Pipeline Review, H1 2016

Acute Lung Injury - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2016’, provides an overview of the Acute Lung Injury pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Liver Cancer - Pipeline Review, H1 2016

Liver Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 ...

  • Industries : Cancer, Therapy, Pathology, Biotechnology, Oncology, Biopharmaceutical, Pharmaceutical
  • Countries : United States
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Biological Therapy, Pathology, Therapy, Biotechnology, Cancer
  • Countries : United States
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical
  • Countries : United States
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States
Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Tumor Necrosis Factor Recepto ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Pathology
  • Countries : United States
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple ...

  • Industries : Cancer, Pathology
  • Countries : United States
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology
  • Countries : United States
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer
  • Countries : United States, World
Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Drug Discovery and Development, Therapy, Pharmaceutical, Oncology
  • Countries : World
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World, United States
Multiple Sclerosis - Pipeline Review, H1 2016

Multiple Sclerosis - Pipeline Review, H1 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape. ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016

Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast ...

  • Industries : Therapy, Biological Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Global Single-Cell Analysis Industry 2016 Market Research Report

Global Single-Cell Analysis Industry 2016 Market Research Report

  • $ 2 850
  • Industry report
  • June 2016
  • by 9Dimen Research

2016 Global Single-Cell Analysis Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Single-Cell Analysis industry, focusing on the main ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, Europe, Asia, North America
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.